// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























1151 Abstracts

A Quality Improvement Initiative to Increase Adherence to Hydroxychloroquine Dosing Guidelines at an Academic Medical Center

Stephanie L. Giattino - American College of Rheumatology (ACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

Adenosine A2A Receptor Stimulation Regulates Autophagy in Chondrocytes

Carmen Corciulo - American College of Rheumatology (ACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

Association of Hydroxychloroquine Use and Incident Atrial Fibrillation in Rheumatoid Arthritis: A Retrospective Study

Aditya Joshi - American College of Rheumatology (ACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Hydroxychloroquine

Association of Hydroxychloroquine Use and Incident Atrial Fibrillation in Systemic Lupus Erythematosus: A Retrospective Study

Aditya Joshi - American College of Rheumatology (ACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

Clinical Efficacy of Leflunomide/Hydroxychloroquine Combination Therapy in Patients with Primary Sjogren’s Syndrome: Results of a Placebo-Controlled Double-Blind Randomized Clinical Trial

Eefje H.M. van der Heijden - American College of Rheumatology (ACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

Clinical Variables and Serologic Markers of Disease Activity Do Not Aid in Early Recognition of Patients with Tubulointerstitial Disease Who Have No Significant Renal Impairment at Time of Biopsy

Beatrice Goilav - American College of Rheumatology (ACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Hydroxychloroquine

HYDROXYCHLOROQUINE (PLAQUENIL) CARDIOTOXICITY: AN UNCOMMON COMPLICATION OF A COMMON MEDICATION

Yogita Rochlani - American College of Cardiology (ACC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

Hydroxychloroquine

AUTOIMMUNE INDUCED HEART BLOCK

Osama Kandalaft - American College of Cardiology (ACC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

TROPHERYMA WHIPPLEI: AN UNUSUAL CAUSE OF MITRAL AND AORTIC VALVE ENDOCARDITIS

Martin Miguel Inocencio Amor - American College of Cardiology (ACC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

Hydroxychloroquine

Spectral domain optical coherence tomography abnormalities preceding visual field changes in hydroxychloroquine retinopathy.

Sean Garrity - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Hydroxychloroquine

Risk factors for hydroxychloroquine retinopathy in the Korean population.

KIM SEEUN - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Hydroxychloroquine

Coding patterns among ophthalmologists for hydroxychloroquine retinal toxicity

Stephan Chiu - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Hydroxychloroquine

Longitudinal changes in eyes with hydroxychloroquine retinal toxicity

Ali M. Allahdina - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Hydroxychloroquine

Long-term progression of hydroxychloroquine retinopathy off the drug

Brandon Pham - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Hydroxychloroquine

Multifocal Electroretinography: An Objective Functional Test for Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity

Adrian C Tsang - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Hydroxychloroquine

Hydroxychloroquine enhances the efficacy of retinal gene therapy

Laurel Clare Chandler - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

Searching for a structural abnormality supportive of the functional anomaly observed in pediatric patients with hydroxychloroquine associated retinal toxicity.

Andre N Ali-Ridha - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

Effect of Chloroquine (Resochin®) and Hydroxychloroquine (Quensyl®) on the ERG b-Wave Amplitude From the Isolated Superfused Vertebrate Retina.

Serge Sjapic - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

Cutaneous polyarteritis nodosa associated with Crohn’s disease with improvement on low-dose dapsone

Isabella Plumptre - American Academy of Dermatology (AAD) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

Hydroxychloroquine

Frontal fibrosing alopecia in Asians: a retrospective clinical study

Kallapan Pakornpadungsit - American Academy of Dermatology (AAD) , 2018

Therapeutic Area

Disease

Drug/Treatment

Dermatology

N/A

Hydroxychloroquine

Copyright © 2026. QuantiNova All rights reserved